Moderna Inc (NAS:MRNA)
$ 132.33 -0.35 (-0.26%) Market Cap: 50.71 Bil Enterprise Value: 43.56 Bil PE Ratio: 0 PB Ratio: 3.95 GF Score: 68/100

Moderna Inc at Jefferies London Healthcare Conference Transcript

Nov 16, 2022 / 01:30PM GMT
Release Date Price: $185.25 (-0.12%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Thanks for joining us on our next session. I'm Michael Yee, Senior Biotechnology Analyst at Jefferies. Very happy to have up here on the stage the President of Moderna, Stephen Hoge. It's great to have you. Thanks for being here with us.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Obviously, a ton of stuff going on. You just reported earnings. We're in the middle of some sort of transition from pandemic to endemic. I think we were commenting here, I guess, we are in endemic because everyone is doing just fine, and we'll deal with that. But also, of course, a lot of important things near term on the platform.

And so I'd love to spend some time talking about, obviously, where we are with COVID and some of the big platform readouts that are going to happen, because I think this is as important as perhaps the Moderna story will obviously have exposure to COVID, but transition to talking about other things.

So maybe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot